에이비온 Stock: price and insider trades · South Korea
1 insider bought €1,486 of shares over the last 90 days, the latest by 우성윤, filed 18 Aug 2026.
에이비온: what insiders have been doing
에이비온, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). Between 1 November 2025 and 1 November 2026, 12 insiders published 30 filings.
Both sides are active: 22 purchases worth €103k and 7 sales, from 11 insiders and 3 insiders respectively. No amount is published for 27 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €57k, the purchase published on 29 April 2026 by 우성윤 is the largest of the period (0.15% of market cap). Among those who bought: 7 senior executives, 1 major shareholder and 1 board member.
In all, 2 purchases were made within 30 days of a purchase by another insider of the company. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (18 August 2026) now reads 84 days. Between a trade and the moment it shows up on DART (FSS), the median delay is 4 days. That lag is the time during which only the insider knows about the trade.
Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 30 filings, this issuer sits above that mark. Since 2021, the database holds 41 purchases and 14 sales by insiders of the company.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySale+8 other insiders
Since the insiders bought
- +336.1%Entry ₩775 · Close at T+90 ₩3,380
- -76.8%Entry ₩2,740 · Close at T+90 ₩636
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 13,642,336 sharesShareKRXDART:20261013000382
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- 3,596 sharesShareKRXDART:20260818000234Canonical exit: 16 Nov 2026 (T+90)
- 35,579 sharesShareKRXDART:20260811000545Canonical exit: 9 Nov 2026 (T+90)
- 102,644 sharesShareKRXDART:20260805000367Canonical exit: 3 Nov 2026 (T+90)
- Other0DART
- 105,761 sharesShareKRXDART:20260805000356Canonical exit: 3 Nov 2026 (T+90)
- Other0DART
- 720,054 sharesShareKRXDART:20260728000424Canonical exit: 26 Oct 2026 (T+90)
- 32,620 sharesShareKRXDART:20260706000267Canonical exit: 4 Oct 2026 (T+90)
- 4,922,000 sharesShareKRXDART:20260615000238
- 4,812,961 sharesKRXDART:20260615000278
- 6,023,494 sharesKRXDART:20260612000235
- 109,039 sharesShareKRXDART:20260608000248Canonical exit: 6 Sept 2026 (T+90)
- 6,023,494 sharesKRXDART:20260526000099Canonical exit: 18 Aug 2026 (T+90)
- 1,000,747 sharesKRXDART:20260522000466
- 1,022,061 sharesShareKRXDART:20260522000450
- 30,000 shares@ ₩2,656.000.12% mcap100.0% of flowShareKRXDART:20260429000771Canonical exit: 26 Jul 2026 (T+90)
- 37,865 shares@ ₩2,619.000.15% mcap100.0% of flowShareKRXDART:20260429000743Canonical exit: 26 Jul 2026 (T+90)
- ●Executives0DART
- 61 sharesShareKRXDART:20251208000177Canonical exit: 8 Mar 2026 (T+90)
- 207 sharesShareKRXDART:20251208000260Canonical exit: 8 Mar 2026 (T+90)
25 of 94 declarations
About 에이비온
Listed on the XKRX market, 에이비온 is a company operating in the healthcare and pharmaceutical sector. It focuses on developing innovative solutions to enhance healthcare.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
